Latest Articles

Publication Date
Salivary miRNAs in the diagnosis of endometriosis An invited narrative scientific literature review, commissioned by European Board and College of Obstetrics and Gynaecology (EBCOG).

Endometriosis is a common gynaecological condition, the diagnosis of which has been made for many years through invasive procedures, such as laparoscopy. In recent years, non-invasive methods have been proposed, …

Published: June 25, 2026, midnight
Endometriosis of the vermiform appendix: a rare cause of acute abdomen in women - case report and review of literature.

Appendicular endometriosis (AE) mimicking appendicitis is very rare. It has been reported only 44 times in the literature from 1975 to 2021. It is one of the causes of acute …

Published: June 25, 2026, midnight
Correction: Endometrioid cancer associated with endometriosis: from the seed and soil theory to clinical practice.

[This corrects the article DOI: 10.3389/fonc.2022.859510.].

Published: June 25, 2026, midnight
Catamenial Pneumothorax as an Underrecognized Manifestation of Thoracic Endometriosis: A 25-Year Single-Center Experience.

Objectives: Catamenial pneumothorax (CP) is a rare but clinically relevant cause of spontaneous pneumothorax (SP) in women and is associated with high recurrence rates. We hypothesized that CP is underrecognized …

Published: June 25, 2026, midnight
'Baylen Out Loud': Baylen Dupree on Her Endometriosis and Family Plans (Exclusive) - Swooon

'Baylen Out Loud': Baylen Dupree on Her Endometriosis and Family Plans (Exclusive) Swooon

Published: June 24, 2026, 8:33 p.m.
Eli Lilly dives into hair loss treatments with investment in AI startup Absci - statnews.com

Eli Lilly dives into hair loss treatments with investment in AI startup Absci statnews.com

Published: June 24, 2026, 8:05 p.m.
ABSI Stock Eyes Best Day Ever After Positive Hair Loss Drug Data, $100M Lilly-Backed Raise - TradingView

ABSI Stock Eyes Best Day Ever After Positive Hair Loss Drug Data, $100M Lilly-Backed Raise TradingView

Published: June 24, 2026, 7:55 p.m.
Exclusive BAC Article: Absci Corporation; Positive Phase 1 Data ABS-201 AGA, Interim And Final POC Data 2nd Half 2026/Early 2027, Respectively, Advancement Endometriosis And Catalysts (NASDAQ:ABSI) - Seeking Alpha

Exclusive BAC Article: Absci Corporation; Positive Phase 1 Data ABS-201 AGA, Interim And Final POC Data 2nd Half 2026/Early 2027, Respectively, Advancement Endometriosis And Catalysts (NASDAQ:ABSI) Seeking Alpha

Published: June 24, 2026, 7:18 p.m.
'It's impacted every job I've had': Women share endometriosis experiences - AOL.com

'It's impacted every job I've had': Women share endometriosis experiences AOL.com

Published: June 24, 2026, 4:39 p.m.
WHO: Key points to note about endometriosis - K24 Digital

WHO: Key points to note about endometriosis K24 Digital

Published: June 24, 2026, 3:51 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!